allantoin has been researched along with Chronic Disease in 8 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Allantoin is an excellent biomarker of oxidative stress in humans as the main product of uric acid oxidation by reactive oxygen species." | 1.56 | Rapid and reliable HILIC-MS/MS method for monitoring allantoin as a biomarker of oxidative stress. ( Hasikova, L; Kalikova, K; Kozlik, P; Stiburkova, B; Zavada, J, 2020) |
| "Allantoin (All) is an oxidative end product of purines in mammals." | 1.34 | Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum/plasma by CE. ( Caussé, E; Couderc, F; Dirat, B; Negre-Salvayre, A; Pradelles, A; Salvayre, R, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Kozlik, P | 1 |
| Hasikova, L | 1 |
| Stiburkova, B | 1 |
| Zavada, J | 1 |
| Kalikova, K | 1 |
| Caussé, E | 2 |
| Fournier, P | 1 |
| Roncalli, J | 1 |
| Salvayre, R | 2 |
| Galinier, M | 1 |
| Pradelles, A | 1 |
| Dirat, B | 1 |
| Negre-Salvayre, A | 1 |
| Couderc, F | 1 |
| Rahamimov, R | 1 |
| Klaus, S | 1 |
| Tur-Kaspa, R | 1 |
| Ogihara, T | 2 |
| Okamoto, R | 2 |
| Kim, HS | 2 |
| Nagai, A | 1 |
| Morinobu, T | 1 |
| Moji, H | 1 |
| Kamegai, H | 1 |
| Hirano, K | 2 |
| Ogihara, H | 2 |
| Tamai, H | 2 |
| Mino, M | 2 |
| Imanishi, M | 1 |
| Doehner, W | 1 |
| Schoene, N | 1 |
| Rauchhaus, M | 1 |
| Leyva-Leon, F | 1 |
| Pavitt, DV | 1 |
| Reaveley, DA | 1 |
| Schuler, G | 1 |
| Coats, AJ | 1 |
| Anker, SD | 1 |
| Hambrecht, R | 1 |
| Jacobi, KH | 1 |
1 trial available for allantoin and Chronic Disease
| Article | Year |
|---|---|
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
Topics: Administration, Oral; Aged; Allantoin; Allopurinol; Blood Flow Velocity; Chronic Disease; Cross-Over | 2002 |
7 other studies available for allantoin and Chronic Disease
| Article | Year |
|---|---|
Rapid and reliable HILIC-MS/MS method for monitoring allantoin as a biomarker of oxidative stress.
Topics: Allantoin; Biomarkers; Chromatography, High Pressure Liquid; Chronic Disease; Cohort Studies; Gout; | 2020 |
Serum allantoin and aminothiols as biomarkers of chronic heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allantoin; Biomarkers; Case-Control Studies; Chronic Dis | 2017 |
Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum/plasma by CE.
Topics: Allantoin; Chronic Disease; Electrophoresis, Capillary; Heart Diseases; Humans; Hypoxanthine; Kidney | 2007 |
Psoriasis is not a contraindication for alpha interferon treatment in patients with chronic hepatitis C.
Topics: Adult; Allantoin; Chronic Disease; Coal Tar; Contraindications; Drug Combinations; Hepatitis C; Huma | 1995 |
New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease.
Topics: Allantoin; Chronic Disease; Female; Free Radicals; Humans; Infant, Newborn; Lung Diseases; Male; Oxy | 1996 |
Oxidation products of uric acid and ascorbic acid in preterm infants with chronic lung disease.
Topics: Allantoin; Ascorbic Acid; Biomarkers; Bronchoalveolar Lavage Fluid; Chronic Disease; Cohort Studies; | 1998 |
[Chronic rhinitis and its treatment].
Topics: Alcohols; Allantoin; Chronic Disease; Humans; Hydantoins; Imidazoles; Naphazoline; Naphthalenes; Nas | 1969 |